Biotech | October 30, 2023
EnginZyme produces key mRNA vaccine ingredient using biocatalysis
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
The company is confident of addressing all the observations within the stipulated time
Profit after tax (before exceptional items) up 23% to Rs 215 crores
This inspection is the fourth major regulatory inspection (after Russia, Canada and Brazil), cleared by this site in the past two years
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
Lupin enters into BTA with Lupin Manufacturing Solutions
The new gummy capabilities include a dedicated R&D lab, an automated production line, and bottle packaging solutions
Lupin is exclusive first-to-file and may be eligible to receive a 180-day exclusivity period at product launch
Tele-MANAS has counseled more than 3,50,000 people till date and currently provides counseling to 2000 people through 44 Tele Manas Cells
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Subscribe To Our Newsletter & Stay Updated
